INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Extensive Stage Sclc Patients Who Were Benefit From First-line Treatment Accept Temozolomide Maintain Therapeutic
- Status
- UNKNOWN
- Phase
- PHASE2
Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
- Status
- TERMINATED
- Phase
- PHASE1
Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
- Status
- WITHDRAWN
- Phase
- PHASE1
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide Chronotherapy for High Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III Gliomas
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
- Status
- COMPLETED
- Phase
- PHASE3
Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2